Log in

OTCMKTS:GNWSF - GeneNews Stock Price, Forecast & News

+0.01 (+50.00 %)
(As of 01/17/2020 04:00 PM ET)
Today's Range
Now: $0.03
50-Day Range
MA: $0.03
52-Week Range
Now: $0.03
Volume13,000 shs
Average Volume13,923 shs
Market Capitalization$7.49 million
P/E RatioN/A
Dividend YieldN/A
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. GeneNews Limited was founded in 1998 and is headquartered in Richmond Hill, Canada.

Industry, Sector and Symbol

Industry Diagnostic substances



Sales & Book Value

Annual Sales$190,000.00
Book Value($0.03) per share


Net Income$-3,940,000.00
Net Margins-2,760.90%


Market Cap$7.49 million
Next Earnings Date2/13/2020 (Estimated)
OptionableNot Optionable

Receive GNWSF News and Ratings via Email

Sign-up to receive the latest news and ratings for GNWSF and its competitors with MarketBeat's FREE daily newsletter.

GeneNews (OTCMKTS:GNWSF) Frequently Asked Questions

What is GeneNews' stock symbol?

GeneNews trades on the OTCMKTS under the ticker symbol "GNWSF."

How were GeneNews' earnings last quarter?

GeneNews Ltd (OTCMKTS:GNWSF) announced its earnings results on Thursday, November, 14th. The company reported ($0.01) earnings per share for the quarter. The business had revenue of $0.02 million for the quarter. View GeneNews' Earnings History.

When is GeneNews' next earnings date?

GeneNews is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for GeneNews.

Has GeneNews been receiving favorable news coverage?

Press coverage about GNWSF stock has trended very negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. GeneNews earned a daily sentiment score of -3.8 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for GeneNews.

Who are some of GeneNews' key competitors?

What other stocks do shareholders of GeneNews own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GeneNews investors own include Pure Energy Minerals (PE), OrganiGram (OGI), BBX Capital (BBXTB), Obsidian Energy (OBE), Canopy Growth (CGC), CytRx (CYTR), Athabasca Oil (ATH), Oritani Financial (ORIT), Newmark Group (NMRK) and Menlo Therapeutics (MNLO).

Who are GeneNews' key executives?

GeneNews' management team includes the folowing people:
  • Mr. James R. Howard-Tripp, Exec. Chairman & CEO
  • Ms. Joanna M. Halsey Esq., Gen. Counsel, Chief Compliance Officer & HR Director of IDL
  • Prof. Choong-Chin Liew Ph.D., Co-Founder
  • Mr. Warren Whitehead, Chief Accountant (Age 67)
  • Mr. David Suria, Sr. Scientist

How do I buy shares of GeneNews?

Shares of GNWSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is GeneNews' stock price today?

One share of GNWSF stock can currently be purchased for approximately $0.03.

How big of a company is GeneNews?

GeneNews has a market capitalization of $7.49 million and generates $190,000.00 in revenue each year. GeneNews employs 16 workers across the globe.View Additional Information About GeneNews.

What is GeneNews' official website?

The official website for GeneNews is http://www.genenews.com/.

How can I contact GeneNews?

GeneNews' mailing address is 70 East Beaver Creek Road Unit 30, Richmond Hill A6, L4B 3B2. The company can be reached via phone at 905-209-2030 or via email at [email protected]

MarketBeat Community Rating for GeneNews (OTCMKTS GNWSF)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  131
MarketBeat's community ratings are surveys of what our community members think about GeneNews and other stocks. Vote "Outperform" if you believe GNWSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GNWSF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel